Sally Howard, PhD

Adaptive Biotechnologies
Seattle, Washington, United States

Adaptive Biotechnologies (Employee, Shareholder)

Presentation(s):

• 144 - Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection

  On Demand